WHEN THE LIFELINE IS CUT:
HOW BUDGET REDUCTIONS AND FOREIGN AID WITHDRAWALS ARE THREATENING SOUTH AFRICA’S PUBLIC HEALTH GAINS
A System Under Threat
South Africa, home to the largest population of people living with HIV globally (estimated at 8 million individuals), has made substantial progress in combating the epidemic over the past two decades. This progress has been driven largely by strong international support, particularly through the U.S.-funded President’s Emergency Plan for AIDS Relief (PEPFAR), which has provided critical resources for treatment, prevention, and research.
However, this progress now faces a major threat. In early 2025, the United States announced a sweeping policy change through an executive order halting all foreign assistance, including funding for health programmes and research. This sudden withdrawal of external support has left South Africa’s health system under severe strain, jeopardising both service delivery and ongoing HIV research. At the same time, domestic budget constraints have further limited the government’s ability to fill the funding gap threatening the sustainability of hard-won public health gains and undermining future progress in HIV control.
The Double Blow: Foreign Aid Withdrawal and Domestic Budget Cuts
PEPFAR funding cuts have severely disrupted South Africa’s HIV response. Previously, the U.S.-funded PEPFAR programme contributed about US$330 million annually, accounting for 17% of the country’s HIV budget. This funding supported thousands of healthcare workers and critical initiatives such as DREAMS, which focused on adolescent girls and young women.
Since the cuts, the impact has been immediate and severe: thousands of health workers have lost their jobs, and essential HIV prevention and treatment services have been suspended—particularly in the Western Cape, Gauteng, and North West provinces. Clinics have closed, forcing patients to seek care at already overstretched public facilities without any corresponding increase in staff or resources.
At the same time, domestic budget pressures have compounded the crisis. Following the 2025 Medium-Term Budget Policy Statement, health infrastructure spending was sharply reduced, leaving more than 1,900 health posts in the Western Cape unfunded and unfilled. Elective surgical services, particularly in orthopaedics, have been scaled back, and funds for locum staff on which many facilities rely to maintain 24-hour coverage—have been withdrawn. In some hospitals, beds have been closed, further reducing service capacity.
Together, these developments threaten to reverse hard-won public health gains and jeopardise the stability of South Africa’s HIV response.
Systemic Consequences: The Fallout So Far
With more than 83% of South Africans relying on public healthcare, the effects of funding cuts are severe. Clinics are now overwhelmed, and services previously delivered by NGOs have been shifted to public facilities without additional resources, further straining an already fragile system. As a result, access to essential services has diminished, and the quality of care is increasingly compromised.
The crisis is not limited to service delivery; it also threatens South Africa’s position as a leader in medical research. The country has historically received over US$400 million annually in research funding from the U.S. National Institutes of Health (NIH), but this support is now collapsing. According to the Treatment Action Group, at least 27 HIV and 20 TB clinical trials are at risk, with many already halted.
Furthermore, academic and research institutions stand to lose up to 30% of their annual research income.
Major universities such as Wits report funding gaps of up to R3.2 billion, leaving thousands of skilled researchers facing unemployment. The sudden loss of foreign sub-awards has also disrupted international collaborations and jeopardised progress in clinical innovation.
Projections: The Human Cost
Projections for South Africa alone are alarming: if PEPFAR funding ends without a planned transition of services, an estimated 601,000 additional HIV-related deaths and 565,000 new infections could occur by 2035.
The global picture is even more concerning. Between 2025 and 2030, the loss of PEPFAR support could lead to over 10 million new HIV infections and 3 million HIV-related deaths erasing two decades of hard-won progress in controlling the epidemic and threatening global public health gains.
Regional Context: A Broader Crisis
South Africa’s crisis is mirrored across its neighbours in Southern and Eastern Africa, where dependence on U.S. funding for HIV prevention is even higher. The United States provides nearly 45% of all HIV prevention financing across 15 high-burden countries.
Some nations are almost entirely reliant on PEPFAR: Malawi (88.5%), Zimbabwe (82.7%), and Mozambique (81.8%), while others, such as Botswana, Kenya, and Namibia, rely on it for less than 25% of their HIV budgets.
The consequences are already visible. In Malawi, HIV prevention education and awareness programmes have been suspended; in Zimbabwe, services for pregnant women living with HIV have been reduced; and in ten countries, the DREAMS programme which supported more than 2 million adolescent girls and young women with HIV care, reproductive health, education, and empowerment has been halted.
These trends place several countries at even greater risk of health system collapse than South Africa, given their higher dependence on foreign aid. Without urgent regional coordination and alternative funding strategies, the crisis could rapidly erode decades of HIV progress and destabilise health outcomes across the African continent.
A Recovery Framework
Addressing this crisis requires immediate and coordinated action. In the short term, South Africa should prioritise re-engaging with U.S. authorities to restore funding or negotiate ethical transitions for key programmes. At the same time, gaps in services and staffing need urgent auditing, while NGOs must be re-engaged to stabilise community-level service delivery. Furthermore, emergency support should be mobilised through Treasury, the private sector, and philanthropic partners to prevent further disruption of essential health services.
Looking ahead, more sustainable strategies are required to prevent similar vulnerabilities. To this end, the government must reduce dependence on single donor sources by partnering with new global and regional funders. In addition, research funding should be integrated into national health policy to ensure consistent and predictable support. Finally, innovation in health financing such as mechanisms successfully employed during the COVID-19 pandemic must be reactivated to build a more resilient, self-reliant, and sovereign health system.
Conclusion: A Tipping Point for Public Health
This funding crisis represents both an immediate threat and a strategic opening. If no action is taken, South Africa risks eroding decades of investment and progress in its health sector, leaving communities vulnerable and reversing hard-earned gains.
Yet, if tackled decisively, this moment can serve as a turning point one where the country strengthens resilience, reduces donor dependence, and builds a health system capable of withstanding future shocks.
The choice is stark, and the window is narrow: action is required now, not only to prevent collapse but to seize the opportunity to design a more sustainable, equitable, and nationally owned health future.

